Giovanni Caforio, MD
President, U.S. Pharmaceuticals, Bristol-Myers Squibb
Giovanni Caforio leads the company’s pharmaceutical business in the U.S., including Puerto Rico. He was previously senior vice president, Global Commercialization, Oncology and Immunology, where he helped re-establish Bristol-Myers Squibb as a leader in oncology.
Giovanni is passionate about bringing innovative new medicines to patients and is excited by the promise of the company’s pipeline. “Having the opportunity to improve people’s health is why a lot of us have chosen to be in the pharmaceutical industry.”
As a leader, Giovanni’s focus is on developing talented leaders with the diverse experiences and competencies needed for the continued success of the company. “My priority is to help the organization successfully bring our extraordinary portfolio of medicines to patients, while at the same time ensuring we are prepared to best meet the challenges that are ahead of us,” Giovanni said.
Giovanni joined Bristol-Myers Squibb in 2000 as vice president and general manager, Italy, in the Worldwide Medicines Group. In 2001, he assumed added responsibility for Greece and Israel, and then all of South East Europe in 2003. In 2004, he was appointed senior vice president, European Marketing and Brand Commercialization. In 2007, he was named senior vice president, U.S. Oncology. Prior to joining Bristol-Myers Squibb, Giovanni spent 12 years with Abbott Laboratories in a number of leadership positions. Born and educated in Italy, Giovanni received his M.D. from the University of Rome. In addition to Italian and English, he is fluent in Spanish, French, and Portuguese. He currently resides in New Jersey with his wife and two young children.